Health Canada has approved the first generic version of Novo Nordisk’s Ozempic, a semaglutide injection by Dr. Reddy’s Laboratories, after the drug’s Canadian patent expired in January. The move could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results